Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Alopecia Areata in Saudi Arabia is costly, mainly due to lost work and medication expenses, needing better diagnosis, treatment, and care.

AI is effective in diagnosing and treating hair disorders, including detecting hair loss and scalp conditions with high accuracy, but it should supplement, not replace, doctor-patient interactions.

A new image-based method improves accuracy in measuring hair loss in mice.

Baricitinib helps regrow hair in teens with severe alopecia areata.

UVA-1 phototherapy might help treat alopecia areata.

Alopecia areata is an autoimmune hair loss condition linked to genetic factors.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

Early biopsy and targeting inflammation can improve treatment for hair loss in androgenetic alopecia.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Hypaphorine from a fungus changes the internal structure of Eucalyptus root hairs, stopping their growth.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

Alopecia areata may be linked to changes in small blood vessels.

The 736T>A mutation in the LIPH gene is common in Japanese people with autosomal recessive woolly hair.

Higher PD-1 levels mean fewer CD8+ T cells in alopecia areata hair follicles.

A 12-year-old boy with PAIS successfully developed male characteristics using high-dose testosterone and anastrozole.

Caregivers of teens with alopecia areata face significant mental and work-related challenges.

A 22-year-old man has alopecia areata, an autoimmune hair loss condition, with various treatments available.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

Trichohyalin may trigger the immune response causing alopecia areata.

Alopecia areata patients don't have increased atherosclerosis risk, but may have higher cardiovascular risk due to smoking, blood sugar, and blood pressure.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

The document's conclusion cannot be summarized because the content is not accessible.